LAB
Standard Biotools
$0.60
−$0.01 (−0.99%)Oct 26, 2026
Key metrics
The numbers that frame LAB today
- Market cap
- $235.55M
- P/E (TTM)
- 2.7
- Gross margin
- 50.5%
- ROIC
- 13.8%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.59
- 52wk High
- $1.72
Growth
Revenue and earnings trend for LAB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LAB
Is Standard Biotools a good buy?
No. Standard Biotools has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case.
What is the market capitalization of LAB?
Standard Biotools's market capitalization is $235.55M.
What is the P/E (TTM) ratio for LAB stock?
Standard Biotools's P/E (TTM) ratio is 2.7, based on trailing earnings.
What is the 52-week high for LAB stock?
The 52-week high for Standard Biotools is $1.72. The current close of $0.60 is 65.1% below that high.
What is the 52-week low for LAB stock?
The 52-week low for Standard Biotools is $0.59. The current close of $0.60 is 1.7% above that low.
Does LAB stock pay dividends?
Standard Biotools does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LAB?
Standard Biotools's Debt / Equity ratio is 0.05.